Lombard Odier Asset Management USA Corp Buys New Shares in Option Care Health, Inc. (NASDAQ:OPCH)

Lombard Odier Asset Management USA Corp purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 1st quarter, Holdings Channel reports. The firm purchased 85,880 shares of the company’s stock, valued at approximately $1,524,000.

Other large investors also recently bought and sold shares of the company. BlackRock Inc. increased its stake in Option Care Health by 66.7% during the first quarter. BlackRock Inc. now owns 6,084,403 shares of the company’s stock worth $107,935,000 after acquiring an additional 2,434,741 shares during the last quarter. Park West Asset Management LLC increased its position in Option Care Health by 57.6% during the 4th quarter. Park West Asset Management LLC now owns 6,302,202 shares of the company’s stock worth $98,566,000 after purchasing an additional 2,302,202 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Option Care Health by 49.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 6,257,384 shares of the company’s stock valued at $111,006,000 after buying an additional 2,068,169 shares during the period. Nuveen Asset Management LLC lifted its position in Option Care Health by 179.0% during the first quarter. Nuveen Asset Management LLC now owns 2,640,085 shares of the company’s stock valued at $46,835,000 after buying an additional 1,693,761 shares in the last quarter. Finally, Luminus Management LLC purchased a new stake in Option Care Health during the first quarter worth approximately $27,266,000. 47.64% of the stock is currently owned by institutional investors.

OPCH traded down $0.07 during trading hours on Thursday, hitting $21.22. The company’s stock had a trading volume of 4,934 shares, compared to its average volume of 1,214,629. The business’s 50-day moving average is $20.20. The company has a quick ratio of 1.17, a current ratio of 1.58 and a debt-to-equity ratio of 1.10. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 416.20 and a beta of 1.12. Option Care Health, Inc. has a fifty-two week low of $10.52 and a fifty-two week high of $22.69.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Thursday, May 6th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04). The business had revenue of $759.20 million for the quarter, compared to analyst estimates of $752.47 million. Option Care Health had a net margin of 0.29% and a return on equity of 0.92%. Option Care Health’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period last year, the business posted ($0.11) earnings per share. Equities analysts expect that Option Care Health, Inc. will post 0.36 earnings per share for the current year.

In other news, Director Harry M. Jansen Kraemer, Jr. bought 40,000 shares of the stock in a transaction that occurred on Wednesday, May 19th. The shares were purchased at an average cost of $17.59 per share, with a total value of $703,600.00. Following the completion of the acquisition, the director now directly owns 83,760 shares in the company, valued at $1,473,338.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Michael H. Shapiro purchased 2,500 shares of the company’s stock in a transaction on Tuesday, May 11th. The stock was acquired at an average price of $16.33 per share, for a total transaction of $40,825.00. Following the completion of the transaction, the chief financial officer now owns 2,500 shares of the company’s stock, valued at approximately $40,825. The disclosure for this purchase can be found here. Insiders have acquired a total of 53,355 shares of company stock worth $922,938 over the last 90 days. 47.00% of the stock is owned by insiders.

Several research analysts have recently weighed in on OPCH shares. The Goldman Sachs Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $20.00 to $25.00 in a research note on Monday. Zacks Investment Research lowered shares of Option Care Health from a “hold” rating to a “sell” rating in a report on Wednesday, July 14th. One analyst has rated the stock with a sell rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $22.36.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies.

Featured Article: How much can an individual set aside as a catch-up contribution?

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH).

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.